---
$id: https://graph.org.ai/products/commodity/51182211
$type: Product
source: UNSPSC
code: "51182211"
title: "Epostane"
class: "51182200"
classTitle: "Drugs for inducing labor"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Epostane

**UNSPSC Code**: 51182211
**Class**: [Drugs for inducing labor](Drugs for inducing labor.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-progestin with the molecular formula C22H31NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6375T36951, chemically known as 4,17-dimethyltrilostane but generally known as epostane, which bears US NIH Compound Identifier 51331. European Medicines Agency schedules Epostane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06582MIG. The term EPOSTANE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). EPOSTANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule epostane under HS 29372300 and SITC 54153. As of Q4 2014, EPOSTANE remains the US FDA Preferred Term for this commodity. Epostane bears US NLM identifiers UMLS ID C0059461 and NCI Concept Code C80687. SMILES: O1C23C(C4C(C5C(CC4)(C(O)(CC5)C)C)CC3)(CC(C(=O)C12C)C#N)C.

